Zevra Therapeutics (ZVRA) Debt Ratio (2014 - 2025)

Zevra Therapeutics has reported Debt Ratio for 8 years, with the latest figure at 0.22 in Q4 2025.

• For the quarter ending Q4 2025, Debt Ratio fell 34.89% year-over-year to 0.22; the trailing twelve-month figure through Dec 2025 stood at 0.22 (down 34.89% YoY), and the FY2025 full-year result was 0.22, down 34.89% from the prior year.
• Debt Ratio for Q4 2025 stood at 0.22, down from 0.23 in the prior quarter.
• The five-year high for Debt Ratio was 0.4 in Q2 2024, with the low at 0.01 in Q1 2021.
• Historically, Debt Ratio has averaged 0.23 across 5 years, with a median of 0.24 in 2025.
• Annual changes were most pronounced in 2023 — Debt Ratio tumbled 65.91% — and 2024, when it soared 742.47%.
• Zevra Therapeutics' Debt Ratio stood at 0.01 in 2021, then soared by 1139.77% to 0.11 in 2022, then soared by 131.79% to 0.25 in 2023, then surged by 34.61% to 0.33 in 2024, then tumbled by 34.89% to 0.22 in 2025.
• The last three Debt Ratio figures came in at 0.22 (Q4 2025), 0.23 (Q3 2025), and 0.24 (Q2 2025), per Business Quant data.